 |
Return Create A Forum - Home |
 |
--------------------------------------------------------- |
|
MS Speaks |
 |
https://msspeaks.createaforum.com |
|
--------------------------------------------------------- |
|
***************************************************** |
|
Return to: OCREVUS (ocrelizumab) |
|
***************************************************** |
|
#Post#: 3052-------------------------------------------------- |
|
(Abst.) Shorter infusion time of ocrelizumab... |
|
By: agate Date: October 12, 2020, 7:25 pm |
|
--------------------------------------------------------- |
|
From PubMed (October 12, 2020), "Shorter infusion time of |
|
ocrelizumab: Results from the randomized, double-blind ENSEMBLE |
|
PLUS substudy in patients with relapsing-remitting multiple |
|
sclerosis": |
|
https://pubmed.ncbi.nlm.nih.gov/33039944/ |
|
#Post#: 3124-------------------------------------------------- |
|
FDA approves shorter infusion time for Ocrevus |
|
By: agate Date: December 15, 2020, 12:51 am |
|
--------------------------------------------------------- |
|
This should be good news for anyone using Ocrevus. The FDA has |
|
approved a 2-hour twice-yearly infusion time for Ocrevus, which |
|
has involved a 3.5-hour infusion time twice a year. |
|
https://www.gene.com/media/press-releases/14890/2020-12-14/fda-approves-genente… |
|
***************************************************** |
